SEARCH RESULTS FOR: 万事达u卡官网(www.usdtcard.org)dUT7(9770 results)

Export results
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

Petrolatum Dressing XEROFORM | SHEET 4 in x 4 in
MCKESSON MEDICAL-SURGICAL INC.
2206
Not in Commercial Distribution

  • 00612479193147 ()
  • 00612479193130 ()
  • 00612479193123 ()


  • Wound-nonadherent dressing, permeable, antimicrobial
Petrolatum Dressing XEROFORM | SHEET 2 in x 2 in
MCKESSON MEDICAL-SURGICAL INC.
2202
Not in Commercial Distribution

  • 00612479193116 ()
  • 00612479193109 ()
  • 00612479193093 ()


  • Wound-nonadherent dressing, permeable, antimicrobial
Petrolatum Dressing XEROFORM | SHEET 1 in x 8 in
MCKESSON MEDICAL-SURGICAL INC.
2201
Not in Commercial Distribution

  • 00612479193086 ()
  • 00612479193079 ()
  • 00612479193062 ()


  • Wound-nonadherent dressing, permeable, antimicrobial
"120 mL USP Sterile Water, Foil Lid Container"
MCKESSON MEDICAL-SURGICAL INC.
37-6210
In Commercial Distribution

  • 00612479199521 ()
  • 00612479168541 ()


  • Wound irrigation sterile water
Saline Wound Flush Sterile 7.1 fl. Oz
MCKESSON MEDICAL-SURGICAL INC.
37-6507
In Commercial Distribution

  • 00612479133761 ()
  • 00612479133709 ()


  • Multi-purpose therapeutic saline solution
The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-R090A
In Commercial Distribution

  • 04540778140875 ()
  • 14540778140872 ()

  • Length: 90 Millimeter


  • Lacrimal tube
The LACRIFLOW is indicated in treatments of epiphora in-patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-R105A
In Commercial Distribution

  • 04540778140868 ()
  • 14540778140865 ()

  • Length: 105 Millimeter


  • Lacrimal tube
The Lacriflow CL is indicated in treatments of epiphora in patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-CL090A
In Commercial Distribution

  • 14540778171395 ()
  • 04540778171398 ()

  • Length: 90 Millimeter


  • Lacrimal tube
The Lacriflow CL is indicated in treatments of epiphora in patients 12 months and older, in cases of: - Canalicular pathologies (stenosis, obstruction, lacerations), - During Dacryocystorhinostomy (conventional or laser), - Congenital nasolacrimal duct obstruction.
KANEKA CORPORATION
LF-CL105A
In Commercial Distribution

  • 04540778171381 ()
  • 14540778171388 ()

  • Length: 105 Millimeter


  • Lacrimal tube
SCD396 @SONICISION CORDLESS ULTRASONIC D
MEDLINE INDUSTRIES, INC.
SCD396R
In Commercial Distribution

  • 20888277674209 ()
  • 10888277674202 ()
SCD396R

  • Laparoscopic blunt dissector
< 1 ... 118 119 120 121 122 ... 977 >